Expansion Plans
Source Article
Celltrion wins 294.9 bln-won drug substance supply deal from global firm | Yonhap News AgencyOK SEOUL, March 17 (Yonhap) -- Celltrion Inc., a major South Korean biopharmaceutical company, said Tuesday it has secured a 294.9 billion-won (US$198 million) contract to supply drug substances to a global pharmaceutical company through 2029. The company currently has …
#Celltrion
#expansion
#manufacturing
#biopharmaceutical
#investment
